← All trials
NCT07213089
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 13, 2020
- Primary completion
- Apr 4, 2022
- Completion date
- May 12, 2022
- First posted
- Oct 8, 2025
- Last posted
- Oct 8, 2025
- Enrollment
- 290
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- BioNet-Asia Co., Ltd.Lead sponsor
- National Science and Technology Development Agency, ThailandCollaborator
- Mahidol UniversityCollaborator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.